Videos / Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

Product Explainer

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler

Description

In this Product Explainer, Respiratory Physician Dr Kwok Yan explains the role of fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler for the maintenance treatment of asthma in adult patients who are not adequately controlled with an ICS+LABA (7 mins).

This educational activity was developed by Healthed at the request of and with funding from GSK.

PM-AU-FVU-OGM-220003 approved June 2022

NEXT LIVE Webcast

Days

Hours

Minutes

Seconds

A/Prof Spiros Fourlanos & Samantha Stuk

Maintaining Muscle Mass & Nutritional Status While Losing Weight on GLP-1RAs

A/Prof Ralph Audehm & A/Prof Jeremy Grummet

Prostate Cancer Screening Recommendations – Case Discussion & Q&A

Dr Alison Chiu

Dry Eye – Practical Management Tips for Better Outcome

Dr Ted Wu

Cardiovascular Outcomes & GLP1 – An Update

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

30 September 2025

expert

Dr Kwok Yan

Respiratory Physician

Product Explainer

Fluticasone furoate, umeclidinium and vilanterol dry powder triple therapy inhaler